Esperion Therapeutics Stock Options
| ESPR Stock | USD 2.20 0.05 2.33% |
Esperion Therapeutics' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.53 with a put-to-call open interest ratio of 0.29 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025. The total put volume is at 37.0, with calls trading at the volume of 750. This yields a 0.05 put-to-call volume ratio.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows Esperion Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Esperion Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Esperion Therapeutics' option, there is no secondary market available for investors to trade.
Esperion Therapeutics Maximum Pain Price Across 2025-03-21 Option Contracts
Max pain occurs when Esperion Therapeutics' market makers reach a net positive position across all Esperion Therapeutics' options at a strike price where option holders stand to lose the most money. By contrast, Esperion Therapeutics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Esperion Therapeutics
Analyzing Esperion Therapeutics' in-the-money options over time can help investors to take a profitable long position in Esperion Therapeutics regardless of its overall volatility. This is especially true when Esperion Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Esperion Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Esperion Therapeutics' stock while costing only a fraction of its price.
Esperion Therapeutics In The Money Call Balance
When Esperion Therapeutics' strike price is surpassing the current stock price, the option contract against Esperion Therapeutics stock is said to be in the money. When it comes to buying Esperion Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Esperion Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Esperion Current Options Market Mood
Esperion Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Esperion Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Esperion Therapeutics' options investors are not very successful. Esperion Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Esperion contract
Base on the Rule 16, the options market is currently suggesting that Esperion Therapeutics will have an average daily up or down price movement of about 0.0956% per day over the life of the 2025-03-21 option contract. With Esperion Therapeutics trading at USD 2.2, that is roughly USD 0.002104. If you think that the market is fully incorporating Esperion Therapeutics' daily price movement you should consider buying Esperion Therapeutics options at the current volatility level of 1.53%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Esperion |
Purchasing Esperion Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Esperion calls. Remember, the seller must deliver Esperion Therapeutics stock to the call owner when a call is exercised.
Esperion Therapeutics Option Chain
When Esperion Therapeutics' strike price is surpassing the current stock price, the option contract against Esperion Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Esperion Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Esperion. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Esperion. It also shows strike prices and maturity days for a Esperion Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ESPR250321C00005500 | 10 | 5.5 | 0.0 - 4.8 | 0.23 | Out |
Call | ESPR250321C00005000 | 989 | 5.0 | 0.0 - 0.25 | 0.05 | Out |
Call | ESPR250321C00004500 | 97 | 4.5 | 0.0 - 0.2 | 0.1 | Out |
Call | ESPR250321C00004000 | 1111 | 4.0 | 0.0 - 0.1 | 0.05 | Out |
Call | ESPR250321C00003500 | 940 | 3.5 | 0.0 - 3.6 | 0.07 | Out |
Call | ESPR250321C00003000 | 2711 | 3.0 | 0.0 - 0.1 | 0.1 | Out |
Call | ESPR250321C00002500 | 6088 | 2.5 | 0.15 - 0.2 | 0.15 | Out |
Call | ESPR250321C00002000 | 1338 | 2.0 | 0.35 - 0.45 | 0.4 | In |
Call | ESPR250321C00001500 | 181 | 1.5 | 0.0 - 1.15 | 0.9 | In |
Call | ESPR250321C00001000 | 308 | 1.0 | 0.0 - 4.8 | 1.25 | In |
Put | ESPR250321P00005500 | 0 | 5.5 | 3.1 - 3.7 | 3.1 | In |
Put | ESPR250321P00005000 | 0 | 5.0 | 2.3 - 4.0 | 2.92 | In |
Put | ESPR250321P00004500 | 1 | 4.5 | 2.05 - 2.75 | 1.14 | In |
Put | ESPR250321P00004000 | 0 | 4.0 | 1.6 - 2.05 | 1.6 | In |
Put | ESPR250321P00003500 | 33 | 3.5 | 0.0 - 1.8 | 1.35 | In |
Put | ESPR250321P00003000 | 96 | 3.0 | 0.65 - 1.25 | 1.83 | In |
Put | ESPR250321P00002500 | 1624 | 2.5 | 0.45 - 0.6 | 0.55 | In |
Put | ESPR250321P00002000 | 2094 | 2.0 | 0.15 - 0.2 | 0.18 | Out |
Put | ESPR250321P00001500 | 200 | 1.5 | 0.0 - 0.15 | 0.22 | Out |
Put | ESPR250321P00001000 | 0 | 1.0 | 0.0 - 4.8 | 4.8 |
Esperion Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Esperion Total Stockholder Equity
Total Stockholder Equity |
|
Esperion Therapeutics Corporate Management
| Benjamin JD | General Secretary | Profile | |
| Benjamin MBA | Chief Officer | Profile | |
| Glenn Brame | Chief Officer | Profile | |
| Tiffany MBA | Associate Communications | Profile | |
| Ben MBA | Chief Officer | Profile | |
| Betty Swartz | Chief Officer | Profile |
Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.